Evolution of Gold and Iron Oxide Nanoparticles in Conjugates with Methotrexate: Synthesis and Anticancer Effects.

X-ray photoelectron spectroscopy X-ray small-angle scattering anticancer drug drug conjugates gold nanoparticles iron oxide nanoparticles metal-vapor synthesis methotrexate

Journal

Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929

Informations de publication

Date de publication:
19 Apr 2023
Historique:
received: 10 03 2023
revised: 02 04 2023
accepted: 17 04 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Au and Fe nanoparticles and their conjugates with the drug methotrexate were obtained by an environmentally safe method of metal-vapor synthesis (MVS). The materials were characterized by transmission and scanning electron microscopy (TEM, SEM), X-ray photoelectron spectroscopy (XPS), and small-angle X-ray scattering using synchrotron radiation (SAXS). The use of acetone as an organic reagent in the MVS makes it possible to obtain Au and Fe particles with an average size of 8.3 and 1.8 nm, respectively, which was established by TEM. It was found that Au, both in the NPs and the composite with methotrexate, was in the Au

Identifiants

pubmed: 37110074
pii: ma16083238
doi: 10.3390/ma16083238
pmc: PMC10146258
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Expert Opin Drug Deliv. 2012 Feb;9(2):151-69
pubmed: 22251428
Nanomedicine (Lond). 2022 May;17(11):753-764
pubmed: 35575008
J Control Release. 2012 Aug 20;162(1):45-55
pubmed: 22698943
Future Med Chem. 2018 Sep 1;10(18):2201-2226
pubmed: 30043641
Molecules. 2018 Jun 28;23(7):
pubmed: 29958427
Expert Opin Drug Deliv. 2014 Sep;11(9):1449-70
pubmed: 24870351
Pharmaceutics. 2023 Mar 20;15(3):
pubmed: 36986860
Nanomedicine (Lond). 2007 Feb;2(1):23-39
pubmed: 17716188
Curr Drug Deliv. 2021;18(6):794-804
pubmed: 32778025
Curr Opin Pharmacol. 2014 Oct;18:18-27
pubmed: 25173782
Pharmaceutics. 2023 Mar 07;15(3):
pubmed: 36986724
Pharmaceutics. 2023 Mar 07;15(3):
pubmed: 36986729
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jul;9(4):
pubmed: 28160445
ACS Nano. 2016 Aug 23;10(8):7428-35
pubmed: 27504667
J Epidemiol Glob Health. 2019 Dec;9(4):217-222
pubmed: 31854162
J Biomed Nanotechnol. 2016 Apr;12(4):667-78
pubmed: 27301193
Adv Sci (Weinh). 2022 Jul;9(20):e2200482
pubmed: 35508896
Sci Rep. 2020 Jul 9;10(1):11292
pubmed: 32647151
Molecules. 2020 Dec 21;25(24):
pubmed: 33371436
Clin Pract. 2023 Jan 28;13(1):177-189
pubmed: 36826158
ACS Omega. 2019 Dec 09;4(26):22214-22227
pubmed: 31891105
Int J Nanomedicine. 2017 Mar 29;12:2457-2468
pubmed: 28408817
Curr Med Chem. 2019;26(35):6493-6513
pubmed: 31057102
RSC Adv. 2020 Mar 12;10(18):10646-10660
pubmed: 35492913
Langmuir. 2007 Nov 20;23(24):12329-36
pubmed: 17960940
Drug Dev Ind Pharm. 2018 Jun;44(6):886-894
pubmed: 29280388
Cancers (Basel). 2023 Feb 25;15(5):
pubmed: 36900250
Int J Nanomedicine. 2012;7:5375-84
pubmed: 23091381
Mol Pharm. 2007 Sep-Oct;4(5):713-22
pubmed: 17708653
J Biomech Eng. 2014 Jul;136(7):
pubmed: 24658653
Iran J Basic Med Sci. 2023 Mar;26(3):285-294
pubmed: 36865038
Carbohydr Polym. 2021 Dec 1;273:118523
pubmed: 34560940
Int J Med Sci. 2020 Oct 18;17(18):2964-2973
pubmed: 33173417
Curr Drug Metab. 2019;20(6):416-429
pubmed: 30227814
Nanotechnology. 2020 Aug 28;31(35):355101
pubmed: 32413875
Biomed Opt Express. 2019 Jun 07;10(7):3152-3182
pubmed: 31467774
Nanomaterials (Basel). 2020 Nov 23;10(11):
pubmed: 33238486
J Mater Chem. 2009 Jan 1;19(35):6400-6406
pubmed: 19915686
Adv Drug Deliv Rev. 2000 Mar 30;41(2):147-62
pubmed: 10699311
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3693-7
pubmed: 20142483
Chem Rev. 2008 Jun;108(6):2064-110
pubmed: 18543879
Nanomedicine (Lond). 2021 Oct;16(24):2155-2174
pubmed: 34565179
Int J Biol Macromol. 2023 Apr 1;233:123388
pubmed: 36706873
Int J Pharm. 2022 Apr 25;618:121605
pubmed: 35227804
J Colloid Interface Sci. 2001 Jun 15;238(2):291-295
pubmed: 11374924
J Nanosci Nanotechnol. 2014 Jan;14(1):402-14
pubmed: 24730271
Sci Rep. 2018 Sep 14;8(1):14067
pubmed: 30218099
J Appl Crystallogr. 2021 Feb 01;54(Pt 1):343-355
pubmed: 33833657
Artif Cells Nanomed Biotechnol. 2018;46(sup1):926-937
pubmed: 29458269
Adv Sci (Weinh). 2022 May;9(16):e2106049
pubmed: 35343105
Int J Nanomedicine. 2018 Sep 17;13:5499-5509
pubmed: 30271143
J Biomed Mater Res A. 2019 Nov;107(11):2492-2500
pubmed: 31298774
Int J Pharm. 2021 Sep 5;606:120848
pubmed: 34216762
Small. 2005 Mar;1(3):325-7
pubmed: 17193451
Nat Protoc. 2008;3(7):1125-31
pubmed: 18600217
Acta Biomater. 2015 Sep;24:140-51
pubmed: 26116986
Exp Biol Med (Maywood). 2014 May 30;239(7):853-861
pubmed: 24879424
Pharmaceutics. 2023 Mar 02;15(3):
pubmed: 36986678
Molecules. 2020 May 08;25(9):
pubmed: 32397080
Mater Today Bio. 2022 Feb 21;14:100223
pubmed: 35243298
J Biomed Nanotechnol. 2015 Apr;11(4):613-22
pubmed: 26310068

Auteurs

Alexander Vasil'kov (A)

A.N. Nesmeyanov Institute of Organoelement Compounds, RAS, 119334 Moscow, Russia.

Anastasiia Voronova (A)

A.N. Nesmeyanov Institute of Organoelement Compounds, RAS, 119334 Moscow, Russia.

Tsvetelina Batsalova (T)

Faculty of Biology, Paisii Hilendarski University of Plovdiv, 4000 Plovdiv, Bulgaria.

Dzhemal Moten (D)

Faculty of Biology, Paisii Hilendarski University of Plovdiv, 4000 Plovdiv, Bulgaria.

Alexander Naumkin (A)

A.N. Nesmeyanov Institute of Organoelement Compounds, RAS, 119334 Moscow, Russia.

Eleonora Shtykova (E)

Shubnikov Institute of Crystallography, FSRC "Crystallography and Photonics", RAS, 119333 Moscow, Russia.

Vladimir Volkov (V)

Shubnikov Institute of Crystallography, FSRC "Crystallography and Photonics", RAS, 119333 Moscow, Russia.

Ivanka Teneva (I)

Faculty of Biology, Paisii Hilendarski University of Plovdiv, 4000 Plovdiv, Bulgaria.

Balik Dzhambazov (B)

Faculty of Biology, Paisii Hilendarski University of Plovdiv, 4000 Plovdiv, Bulgaria.

Classifications MeSH